Bill Commons

NY S 8380

in committee

Requires covered entities report to the department of health regarding certain 340B drug discounts

New York · 2025-2026 Regular Session · upper

Quick answers

Did NY S 8380 pass?

Not yet. NY S 8380 is in committee as of 2026-05-12 and has not come to a final vote. Latest recorded action (2026-05-12): PRINT NUMBER 8380A

What is NY S 8380 about?

Requires covered entities report to the department of health regarding certain 340B drug discounts and what percentage of patients benefit from such discounts.

Who sponsors NY S 8380?

Siela Bynoe is the primary sponsor of NY S 8380, joined by 4 cosponsors.

Description

Requires covered entities report to the department of health regarding certain 340B drug discounts and what percentage of patients benefit from such discounts.

Introduced
Latest action
2026-05-12 — PRINT NUMBER 8380A
Bill type
bill
Last updated

Sponsors

  • Siela Bynoeprimary
  • Leroy Comriecosponsor
  • John Liucosponsor
  • Kevin S. Parkercosponsor
  • Lea Webbcosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-06-06

    REFERRED TO RULES

    referral-committee

  2. 2026-01-07

    REFERRED TO HEALTH

    referral-committee

  3. 2026-05-12

    AMEND AND RECOMMIT TO HEALTH

    amendment-passage,referral-committee

  4. 2026-05-12

    PRINT NUMBER 8380A

    amendment-passage

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 8380. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.